Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Combined thrombolytic/neuroprotective agents more effective in treating stroke

April 19, 1996

Nerve growth synthesis inducers produce neuroprotective effects

April 19, 1996

SKB reports calcium antagonists for stroke

April 19, 1996

New Takeda compounds suppress increased vascular permeability

April 19, 1996

Lilly reports cannabinoid receptor antagonists

April 19, 1996

Dolasetron submitted for approval in U.S.

April 19, 1996

Cerebyx approvable in USA

April 19, 1996

Myotrophin NDA submission on track

April 19, 1996

GP-3269, new AK inhibitor from Gensia

April 19, 1996

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...